Studies of patients with dominantly inherited Alzheimer’s disease have demonstrated that amyloid-beta and tau accumulate for many years before pathologic changes in memory and executive function1,2, and Aβ levels peak around the time clinical symptoms manifest3. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.